Coherus Oncology Inc Sustainability Reports
Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493007IL8W5MV932D26
FIGI: BBG0063N8V87
2 reports from 2024 to 2025
